Log In
Print
BCIQ
Print
Print this Print this
 

CTx-0357927

  Manage Alerts
Collapse Summary General Information
Company Cancer Therapeutics CRC Pty. Ltd.
DescriptionInhibitor of VEGF receptor 3 (FLT4; VEGFR-3)
Molecular Target Vascular endothelial growth factor (VEGF) receptor 3 (FLT4) (VEGFR-3)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation

Partner

Bionomics Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today